Brandon Woodard, MD
Obstetrics & Gynecology · Clayton, NCNPI 1134419633
Payments from drug & device makers
Across 231 payments — averaging $16.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$914
- Novo Nordisk$335
- Mayne Pharma Commercial LLC$258
- Therapeuticsmd, Inc.$254
- Exeltis, USA Inc.$196
- Daiichi Sankyo Inc.$182
- plus $2K from 33 others
What the payments were for
- Food & beverage$3,787100%
- Education$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 52 | $914 |
| Novo Nordisk | 20 | $335 |
| Mayne Pharma Commercial LLC | 15 | $258 |
| Therapeuticsmd, Inc. | 20 | $254 |
| Exeltis, USA Inc. | 12 | $196 |
| Daiichi Sankyo Inc. | 11 | $182 |
| Astellas Pharma US Inc | 12 | $181 |
| Pfizer | 10 | $162 |
| Avion Pharmaceuticals | 8 | $124 |
| Biogen | 6 | $122 |
| Sage Therapeutics, LLC | 6 | $119 |
| Lupin Inc. | 8 | $107 |
| Organon | 7 | $92 |
| Agile Therapeutics, Inc. | 5 | $83 |
| Currax Pharmaceuticals LLC | 5 | $75 |
| Baxter Healthcare | 3 | $63 |
| Coopersurgical, Inc. | 3 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $43 |
| Shield Therapeutics Inc | 2 | $37 |
| Sumitomo Pharma America, Inc. | 2 | $34 |
| Endo Pharmaceuticals Inc. | 2 | $33 |
| Medtronic | 1 | $29 |
| Lilly USA, LLC | 2 | $29 |
| LSI Solutions Inc | 1 | $27 |
| Evofem Biosciences, Inc. | 1 | $24 |
| Vertical Pharmaceuticals, LLC | 1 | $22 |
| Scynexis, Inc. | 1 | $21 |
| Johnson & Johnson | 1 | $20 |
| Bayer | 1 | $18 |
| Exact Sciences | 1 | $17 |
| Mylan Pharmaceuticals Inc. | 1 | $16 |
| Coloplast | 1 | $16 |
| Vivus LLC | 1 | $16 |
| Duchesnay USA Incorporated | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Tricoast Surgical Solutions LLC | 1 | $14 |
| AMAG Pharmaceuticals, Inc. | 1 | $13 |
| Mission Pharmacal Company | 1 | $12 |
| Aspira Women's Health Inc | 1 | $11 |
How this compares
$3,800 in reported general payments places this provider in the 85th percentile of 1,344 obstetrics & gynecology providers in North Carolina.
See all obstetrics & gynecology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 16 | $907 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Clayton
- Laura McKainWilmington$2.6M
- Robert ParkerWinston-Salem$2.1M
- Allison PuechlCharlotte$1.6M
- Jeffrey MichelsonNew Bern$1.2M
- Robert LittletonRaleigh$976K
- Donald HornerCharlotte$907K
- Rebecca Dunsmoor SuMorrisville$837K
- Ann CollinsRaleigh$701K
- Kathryn PattenHendersonville$550K
- Mohamad Mehdi ParvaElizabeth City$538K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.